Filing Details
- Accession Number:
- 0001640455-21-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-22 18:35:57
- Reporting Period:
- 2021-01-20
- Accepted Time:
- 2021-01-22 18:35:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640455 | Jounce Therapeutics Inc. | JNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1340881 | C Kimberlee Drapkin | C/O Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge MA 02139 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-20 | 3,016 | $0.48 | 58,897 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-20 | 6,775 | $0.74 | 65,672 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-20 | 3,710 | $2.36 | 69,382 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-20 | 16,201 | $12.03 | 53,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-20 | 10,000 | $10.03 | 43,181 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-21 | 3,799 | $2.36 | 46,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-21 | 3,799 | $12.00 | 43,181 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-20 | 3,016 | $0.00 | 3,016 | $0.48 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-20 | 6,775 | $0.00 | 6,775 | $0.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-20 | 3,710 | $0.00 | 3,710 | $2.36 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-21 | 3,799 | $0.00 | 3,799 | $2.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-27 | No | 4 | M | Direct | |
| 0 | 2025-01-12 | No | 4 | M | Direct | |
| 209,804 | 2025-08-25 | No | 4 | M | Direct | |
| 206,005 | 2025-08-25 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2019, and amended on November 30, 2020. The Reporting Person exercised no discretion with respect to these transactions.
- Represents the weighted average share price of an aggregate total of 16,201 shares sold in the price range of $12.00 to $12.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $10.00 to $10.12 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 3,799 shares sold at $12.00 and $12.01 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option shares vested and became exercisable in 12 monthly installments from October 9, 2013.
- The option shares vested and became exercisable in 12 monthly installments from October 9, 2014.
- 25% of the option shares vested and became exercisable on August 26, 2016 and the remainder of the option shares vest and become exercisable in 12 quarterly installments thereafter.
Billionaire Hedge Funds
